Viewing Study NCT07076550

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2025-12-28 @ 5:08 AM
Study NCT ID: NCT07076550
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma
Sponsor: Alpha-9 Oncology USA Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma Metastatic View
None Uveal Melanoma, Metastatic View
None Mucosal Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic Melanoma View
None Melanoma View
None Radiopharmaceuticals View
None Theranostic View